ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,016,270 | +30.2% | 96,750 | +49.6% | 0.00% | 0.0% |
Q2 2023 | $1,549,134 | +85.7% | 64,682 | +45.9% | 0.00% | +200.0% |
Q1 2023 | $834,197 | +38.7% | 44,325 | +17.3% | 0.00% | 0.0% |
Q4 2022 | $601,553 | -12.2% | 37,786 | -9.7% | 0.00% | 0.0% |
Q3 2022 | $685,000 | -1.6% | 41,868 | -15.2% | 0.00% | 0.0% |
Q2 2022 | $696,000 | -53.2% | 49,381 | -19.6% | 0.00% | -50.0% |
Q1 2022 | $1,487,000 | -22.6% | 61,397 | -25.4% | 0.00% | -33.3% |
Q4 2021 | $1,920,000 | +11.2% | 82,258 | -20.9% | 0.00% | 0.0% |
Q3 2021 | $1,727,000 | -18.6% | 104,000 | +19.5% | 0.00% | 0.0% |
Q2 2021 | $2,122,000 | +8.8% | 87,027 | +15.1% | 0.00% | 0.0% |
Q1 2021 | $1,951,000 | -14.6% | 75,637 | +77.0% | 0.00% | -25.0% |
Q4 2020 | $2,284,000 | +88.6% | 42,726 | +45.5% | 0.00% | +33.3% |
Q3 2020 | $1,211,000 | +52.7% | 29,368 | +79.4% | 0.00% | +50.0% |
Q2 2020 | $793,000 | +31.1% | 16,366 | +14.4% | 0.00% | 0.0% |
Q1 2020 | $605,000 | +7.8% | 14,312 | +9.2% | 0.00% | +100.0% |
Q4 2019 | $561,000 | +155.0% | 13,101 | +124.5% | 0.00% | -75.0% |
Q3 2017 | $220,000 | – | 5,836 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |